Jaipur, India, 302019
BUDEPRESS F is a dual-action respiratory suspension combining Formoterol Fumarate and Budesonide, formulated to manage chronic respiratory disorders effectively. Formoterol is a long-acting beta2-agonist (LABA) that helps relax the airway muscles, promoting easier breathing, while Budesonide, a corticosteroid, works to reduce inflammation, swelling, and mucus production in the lungs. Designed for nebuliser administration, BUDEPRESS F ensures direct delivery of medication to the lungs, providing both rapid symptom relief and long-term respiratory control. It is ideal for patients with asthma, chronic bronchitis, or COPD, offering improved airflow and better quality of life. Budesonide nebuliser suspension bp uses BUDEPRESS F is prescribed for: Long-term management and prevention of asthma attacks. Control of Chronic Obstructive Pulmonary Disease (COPD) symptoms. Relief from wheezing, shortness of breath, and chest tightness. Reducing airway inflammation and mucus accumulation. Enhancing overall lung function and oxygen intake. This nebuliser suspension is designed to be administered via a nebuliser, ensuring effective delivery to the lungs for faster and sustained results. Benefits Dual-Action Therapy: Combines a bronchodilator (Formoterol) with an anti-inflammatory agent (Budesonide) for comprehensive respiratory care. Rapid Relief: Helps quickly alleviate wheezing and breathlessness. Long-Term Control: Budesonide reduces airway inflammation, preventing flare-ups. Improves Lung Function: Enhances oxygen intake and respiratory efficiency. Nebuliser Friendly: Delivers medication directly to the lungs, maximizing effectiveness. Reduces Exacerbations: Helps decrease emergency visits due to asthma or COPD attacks. Budesonide nebuliser suspension bp Dosage Adults: Usually, 1–2 nebuliser doses once or twice daily, as prescribed by a healthcare professional. Children: Dose must be determined by a pediatrician based on age and severity of symptoms. Administer using a nebuliser, inhaling slowly and deeply until the full dose is delivered. Rinse your mouth after each session to reduce the risk of oral thrush. Always follow the prescribed regimen; do not increase or decrease the dose without consulting your doctor. Side Effects Common side effects may include: Throat irritation or hoarseness Cough Mild headache or dizziness Palpitations or tremors Oral fungal infections (oral thrush) Serious side effects are rare but may include allergic reactions, severe difficulty in breathing, or rapid heartbeat. Seek immediate medical attention if severe symptoms occur. Precautions and Warning Pregnancy & Breastfeeding: Only use under medical supervision. Heart Conditions: Consult your doctor if you have arrhythmia, hypertension, or other cardiovascular conditions. Immunocompromised Patients: May increase susceptibility to infections. Not for Acute Attacks: Keep a rescue inhaler for sudden asthma symptoms. Allergies: Avoid if allergic to Formoterol, Budesonide, or any excipients. Storage: Store in a cool, dry place below 30°C, away from sunlight, and out of children’s reach. Conclusion BUDEPRESS F (Formoterol Fumarate & Budesonide Respirator Suspension) is a clinically proven dual-action therapy for the effective management of asthma and COPD. By combining rapid bronchodilation with long-term anti-inflammatory control, it helps prevent exacerbations, improves breathing, and enhances overall lung function. Regular use as prescribed ensures consistent respiratory control, making BUDEPRESS F a reliable and effective solution for patients seeking better breathing, fewer attacks, and improved quality of life.
| Composition | Formoterol Fumarate 20 mcg, Budesonide 0.5 mg |
| Country of origin | INDIA |
| Brand Name: | BUDEPRESS F |
| Manufactured By | Steris Healthcare Pvt Ltd |
| Storage | Store In A Cool & Dry Place |
| Packaging Size | 50 Respules |
| Dosage | As Directed By the Physician |